Delaying surgical inguinal hernia repair in preterm infants reduces risks

Delaying surgical inguinal hernia repair in preterm infants until after discharge from the neonatal intensive care unit appears to reduce the likelihood of serious adverse events, according to researchers at UTHealth Houston.

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program – Biotech Investments

Issuer: CureVac / Key word(s): Alliance/Study results 12.09.2024 / 12:57 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Partner GSK

September 13, 2024

Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference | Psychedelic Invest

Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of

July 12, 2024

Savara’s rare lung disease treatment passes Phase 3

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.